Generic Drug News and Research

RSS

Generic Drugs are official nonbrand names by which medicines are known. Generic names usually refer to the chemical name of the drug.

China Pharma Holdings announces completion of clinical trials for Candesartan

China Pharma Holdings, Inc., which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that the Company has completed clinical trials for Candesartan, an anti-hypertension drug, and submitted the generic drug production application to the SFDA.

21 Jan 2010

Endo Pharmaceuticals' partners receive Paragraph IV Certification Notice regarding LIDODERM

Endo Pharmaceuticals announced today that its partners, Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. have received a Paragraph IV Certification Notice from Watson Laboratories, Inc. advising of the filing of an Abbreviated New Drug Application (ANDA) for a generic version of LIDODERM® (lidocaine topical patch 5%).

20 Jan 2010

FTC wants to ban 'pay-to-delay' settlements related to generic drugs

The Associated Press/USA Today: "The Federal Trade Commission says patent settlements between drugmakers that cost U.S. consumers billions each year are on the rise. The agency reported Wednesday that the number of lucrative settlements between brand-name and generic drug companies rose to 19 last year from 16 in 2008 and 14 the year before."

18 Jan 2010

Med-Vision implements Verisk Health’s Explorer solution to reduce clients' healthcare costs

Verisk Health, Inc. today announced that Med-Vision, LLC helped clients reduce healthcare costs by 10 to 12 percent with Verisk Health’s Explorer solution. Verisk Health is a global leader in identifying, analyzing, and predicting healthcare risk. Med-Vision is a leading medical consulting company.

12 Jan 2010

Diabetes patients with Part D coverage gap are less likely to stick to their medications

Medicare recipients with diabetes who have a gap in their Part D prescription drug benefits—known as the "doughnut hole" — have higher out-of-pocket drug costs and are less likely to stick to their medications than those who have supplemental drug benefits, a new study confirms.

7 Jan 2010

HealthPartners programs reduce medical expenses by more than $137 million

HealthPartners programs designed to improve the quality and efficiency of care reduced medical expenses by more than $137 million last year, according to the organization’s 2009 Return on Investment report.

31 Dec 2009

Walgreens discloses record first-quarter fiscal 2010 results

Walgreens today announced record earnings and sales for the first quarter of fiscal year 2010.

21 Dec 2009

CIGNA suggests the 'To Do' list to stay healthy during this holiday season

‘Tis the season for celebrating with family and friends -- and searching for those perfect gifts. CIGNA suggests adding another item to the top of the holiday “To Do” list: Be sure to take needed medications to stay healthy this holiday season and into the New Year.

19 Dec 2009

Wisconsin cuts $600 million from Medicaid budget, still faces deficit

The Associated Press reports that the top Wisconsin health official said Thursday that the state is "on track to cut more than $600 million from Medicaid, but even with those reductions, high demand from the poor for insurance benefits could result in up to a $150 million shortfall."

18 Dec 2009

NICE guidelines limit options for low cost osteoporosis drugs

Low cost osteoporosis drugs are strictly rationed for the under 75s, and UK physicians hampered by restrictive guidelines, according to findings which appear today in the journal Therapeutic Advances in Musculoskeletal Disease, published by SAGE.

14 Dec 2009

Forbes examines ongoing discussions over HIV/AIDS drugs patent pools

Forbes examines the ongoing discussions between aid groups and drug manufacturers over the formation of an HIV/AIDS drugs patent pool to help drive down costs for developing countries.

13 Dec 2009

Cephalon's lawsuit against Teva Pharmaceuticals for patent infringement of NUVIGIL tablets

Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc. for infringement of U.S. Patent Nos. 7,132,570 (the "'570 Patent"), 7,297,346 (the "'346 Patent") and RE37,516 (the "'516 Patent") for the Cephalon product NUVIGIL® (armodafinil) Tablets [C-IV].

3 Dec 2009

Individuals in CDHPs likely to exhibit a number of cost-conscious behaviors

Individuals in consumer-driven health plans (CDHPs) are more likely than those with traditional coverage to exhibit a number of cost-conscious behaviors, to be more engaged in wellness programs, and to be more inclined to think that financial incentives matter in holding down costs, according to survey results released today by the nonpartisan Employee Benefit Research Institute (EBRI).

2 Dec 2009

Pharmacists provide strategies to minimize disruption on common prescription drugs

Seniors may find that many common prescription drugs that Medicare Part D has covered for years may suddenly be denied due to a new policy being implemented by the Centers for Medicare and Medicaid Services (CMS).

2 Dec 2009

Codexis signs second agreement with Teva Pharmaceutical Industries

Codexis, Inc. today announced an expansion of its relationship and the signing of its second agreement this year with Teva Pharmaceutical Industries Ltd., the world's largest generic drug manufacturer. The new agreement covers three undisclosed pharmaceutical products.

1 Dec 2009

NCKU, ScinoPharm Taiwan sign MOU to establish university-industry cooperation

National Cheng Kung University (NCKU), Taiwan signed a MOU with ScinoPharm Taiwan Ltd. on Nov. 24th.

27 Nov 2009

Millipore completes acquisition of the remaining 60% ownership of its joint-venture in India

Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it has acquired the remaining 60 percent ownership of its joint-venture in India, Millipore India Pvt. Ltd. The new subsidiary will enable Millipore to invest in initiatives that will drive growth and expand its leadership in India’s thriving life science market.

23 Nov 2009

Significant increases in IT use have not reduced drug review process

Drug approvals are taking just as long as they ever did despite increased expenditure on new information technology at the Food and drug Administration. So says a statistical analysis of approval intervals from 1997 to 2006, published in the International Journal of Electronic Healthcare.

20 Nov 2009

Medtipster announces new promotion to help Michigan residents save on their prescription costs

Medtipster, the company behind the new online healthcare search engine and price comparator Medtipster.com, is pleased to announce a new promotion to help Michigan residents save on their prescription costs.

6 Nov 2009

DOJ investigates alleged fraud by drugmakers; sanctions on wellcare lifted

"A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry," Business Week reports. "Critics say the continuing probe, which involves Johnson & Johnson (JNJ) and other major drugmakers, highlights what they describe as an industry practice of paying money to outfits that provide drugs to consumers, in return for preferential treatment."

6 Nov 2009